Backed by extensive experience in the healthcare sector, the fund manager has executed over 50 investments, primarily focusing on innovative biotech and medical technology companies. Active across North America and Europe, the manager emphasizes a data-driven approach, targeting early to growth-stage firms. Notable exits include several successful IPOs and acquisitions that have significantly contributed to the fund’s performance. This strategic style prioritizes operator-first insights, ensuring optimal alignment with market demands and trends.